EWA
TNXP icon

EverSource Wealth Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

EverSource Wealth Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17K Buy
376
+375
+37,500% +$5.77K ﹤0.01% 3255
2025
Q4 		$16 Buy
+1
New +$18 ﹤0.01% 4229

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

EverSource Wealth Advisors's TNXP Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Tonix Pharmaceuticals (TNXP) stake by 37,500% in Q1 2026, buying an estimated $5.77K and bringing the position to 376 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

EverSource Wealth Advisors first reported a position in TNXP in Q4 2025 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • EverSource Wealth Advisors held 376 shares of Tonix Pharmaceuticals worth $5.17K as of Q1 2026.
  • EverSource Wealth Advisors bought 375 Tonix Pharmaceuticals shares in Q1 2026, an estimated $5.77K.
  • Tonix Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3255 holding.
  • EverSource Wealth Advisors first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.